Coronavirus C-19 “Vaccine” Side (Adverse) Effects Detox Protocol

$85 | 45 min

Recover your natural state of balance with our internationally compiled Detox Protocol

Close to four million adverse reactions (side effects) have been reported in people worldwide after receiving the coronavirus C-19 “vaccine” (including fatigue, brain fog, and clotting; and respiratory, neurological, and heart and brain disorders) (also see References section below).

Some of the reasons that have been discussed so far include Spike (S) protein over-activity or over-production, interference with our ACE2 receptors or protease/furin enzymes, over-stimulation of interleukin IL-6, and excessive production of fibrin-like proteins.

When we are able to influence or reverse the action of some of these factors (e.g. with natural substances or blood purification programmes when using Frequency Therapy), some of these side effects may be able to be neutralized or inhibited.

If you are experiencing strong side effects after receiving the coronavirus C-19 vaccine, we may be able to recommend a detailed Detox Protocol, compiled by international scientists, doctors, and holistic practitioners. This Detox Protocol employs natural substances that are specific to the C-19 vaccine detox targets (e.g. Spike (S) protein, ACE2 receptors, protease enzymes, IL-6), as well as blood purification programmes.

REFERENCES

2024

Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination: A case report (2024).

Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study (2024).

SARS-CoV-2 mRNA vaccine-related myocarditis and pericarditis: An analysis of the Japanese Adverse Drug Event Report database (2024).

Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis (2024).

Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study (2024).

Risk of myocarditis after three doses of COVID-19 mRNA vaccines in the United States, 2020-2022: A self-controlled case series study (2024).

SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung (2024).

New-onset of giant cell arteritis with ischemic optic neuropathy following the seventh-dose of COVID-19 mRNA vaccination: A case report and literature review (2024).

2023

Recurrent livedo-like skin lesions following a vector-based COVID-19 vaccine (2023).

Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events (2023).

Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England (2023).

A Case of de novo Annular-plaque Type Psoriasis Following Oxford- AstraZeneca COVID-19 Vaccination (2023).

Vitreous Hemorrhage and Long-Lasting Priapism After COVID-19 m-RNA Based Vaccine: A Case Report (2023).

Cardiac side effects of RNA-based SARS-CoV-2 vaccines: Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure (2023).

COVID-19 vaccination and menstrual disorders among women: Findings from a meta-analysis study (2023).

Biodistribution of mRNA COVID-19 vaccines in human breast milk (2023).

ChAdOx1 SARS-CoV-2 vaccination: A putative precipitant of adrenal crises (2023).

Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination (2023).

A Case of Acquired Aplastic Anemia after Severe Hepatitis- Probably Induced by the Pfizer/BioNTech Vaccine: A Case Report and Review of Literature (2023).

A Case of Acute Retinal Necrosis Associated with Reactivation of Varicella Zoster Virus after COVID-19 Vaccination (2023).

A Case of Bilateral Frosted Branch Angiitis after mRNA COVID-19 Vaccination (2023).

2022

Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins (2022).

Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature (2022).

Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study (2022).

A case of cerebral venous sinus thrombosis following the vaccination with Tozinameran (2022).

A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis (2022).

Reversible cytotoxic lesion of the corpus callosum following SARS-CoV-2 mRNA vaccine administration: a finding to be aware of (2022).

Acute Vulvar Aphthous Ulceration After COVID-19 Vaccination: 3 Cases (2022).

Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature (2022).

Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series (2022).

A Case Series of Myocarditis Following Third (Booster) Dose of COVID-19 Vaccination: Magnetic Resonance Imaging Study (2022).

Acute acalculous cholecystitis following COVID-19 vaccination: a case report (2022).

SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome (2022).

Acquired Hemophilia A Developed Post COVID-19 Vaccine: An Extremely Rare Complication (2022).

COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment (2022).

Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination (2022).

Hemophagocytic lymphohistiocytosis following mRNA-1273 COVID-19 vaccination (2022).

Herpes Zoster Ophthalmicus after Pfizer BNT162b2 and Moderna mRNA-1273 vaccination in two young and immunocompetent patients (2022).

IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination (2022).

Marginal keratitis following COVID 19 vaccination (2022).

Miller Fisher syndrome following Pfizer COVID-19 vaccine (2022).

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Transverse Myelitis Probably Associated With SARS-CoV-2 mRNA Vaccines: Two Case Reports (2022).

Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines (2022).

Myocarditis following mRNA vaccine (2022).

New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure (2022).

Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases (2022).

New-Onset Systemic Lupus Erythematosus after mRNA SARS-CoV-2 Vaccination (2022).

Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection (2022).

Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine (2022).

Serious shoulder injury after COVID-19 vaccination (2022).

Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence? (2022).

Severe Rhabdomyolysis Complicated With Acute Kidney Injury Required Renal Replacement Therapy After Pfizer COVID-19 Vaccine (2022).

The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan (2022).

Bilateral Sequential Acute Macular Neuroretinopathy in an Asian Indian Female withβThalassemia Trait following (Corona Virus Disease) COVID-19 Vaccination and Probable Recent COVID Infection - Multimodal Imaging Study (2022).

Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019 (2022).

[F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis (2022).

Acute-onset polyradiculoneuropathy after SARS-CoV2 vaccine in the West and North Midlands, United Kingdom (2022).

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases (2022).

Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (2022).

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines (2022).

Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus (2022).

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents (2022).

The effects of intravascular photobiomodulation on sleep disturbance caused by Guillain-Barrésyndrome after Astrazeneca vaccine inoculation: Case report and literature review (2022).

F-Fluciclovine-Avid Axillary Lymph Nodes After COVID-19 Vaccination on PET/CT for Suspected Recurrence of Prostate Cancer (2022).

A 54-Year-Old Man With Migratory Pulmonary Consolidation and Progressive Dyspnea (2022).

A Case of Adult Multisystem Inflammatory Syndrome Following COVID-19 Vaccine (2022).

A case of an elderly female who developed subacute pleuropericarditis following BNT162b2 mRNA COVID-19 vaccination (2022).

A Case of Atypical Unilateral Optic Neuritis Following BNT162b2 mRNA COVID-19 Vaccination (2022).

A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination (2022).

A case of encephalitis following COVID-19 vaccine (2022).

A Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) Post ChAdOx1 nCoV-19 Vaccination (2022).

A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination (2022).

A case of hemophagocytic lymphohistiocytosis after BNT162b2 COVID-19 (Comirnaty®) vaccination (2022).

A Case of Markedly Elevated Isolated Alkaline Phosphatase in the Third Trimester of Pregnancy (2022).

A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report (2022).

A Case of Minimal Change Disease after SARS-CoV-2 Vaccination under the Age of 18 (2022).

A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination (2022).

A case of myopericarditis recurrence after third dose of BNT162b2 vaccine against SARS-CoV-2 in a young subject: link or causality? (2022).

A case of polyneuropathy after COVID-19 vaccine (2022).

2021

Case Report: Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur After COVID-19 Vaccination (2021).

A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine (2021).

A Case of Cervical Lymphadenopathy After Vaccination Against COVID-19 (2021).

A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis (2021).

A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization (2021).

A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination (2021).

A case of delayed inflammatory filler reaction following vaccination with succesful response to colchicine (2021).

COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia: A Case Series (2021).

Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review (2021).

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.

Myocarditis following COVID-19 mRNA vaccination (2021).

Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data (2021).

Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management (2021).

Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19 (2021).

Uveitis and Other Ocular Complications Following COVID-19 Vaccination (2021).

A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination (2021).

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination - A Case Report (2021).

Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination (2021).

Bell's Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine (2021).

Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients (2021).

A case report: symptomatic pericarditis post-COVID-19 vaccination (2021).

A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination (2021).

Acute autoimmune transverse myelitis following COVID-19 vaccination: A case report (2021).

Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? (2021).

Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose (2021).

Facial Diplegia: A Rare, Atypical Variant of Guillain-BarréSyndrome and Ad26.COV2.S Vaccine (2021).

Fatal cerebral haemorrhage after COVID-19 vaccine (2021).

Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients (2021).

Guillain-Barré Syndrome following ChAdOx1-S/nCoV-19 Vaccine (2021).

Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report (2021).

Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine (2021).

Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine (2021).

Isolated Tachycardia Presenting After Pfizer-BioNTech COVID-19 Vaccination (2021).

Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination (2021).

Parsonage-Turner Syndrome After COVID-19 Vaccination: A Case Report (2021).

Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine (2021).

Possible HSP reactivation post-COVID-19 vaccination and booster (2021).

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination (2021).

Reactive arthritis after COVID-19 vaccination (2021).

Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine (2021).

Subacute thyroiditis post-Pfizer-BioNTech mRNA vaccination for COVID-19 (2021).

Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine (2021).

Tolosa-Hunt Syndrome Presenting After COVID-19 Vaccination (2021).

Vestibular neuritis after COVID-19 vaccination (2021).

Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data (2021).

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study (2021).

Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services (2021).

A Case of Hepatotoxicity After Receiving a COVID-19 Vaccine (2021).

A case of longitudinally extensive transverse myelitis following vaccination against Covid-19 (2021).

2020

Acute Myopericarditis after COVID-19 Vaccine in Teenagers (2020).

Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia (2020).

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children (2020).

A Case of Acute Pericarditis After COVID-19 Vaccination (2020).

A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine (2020).